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The constitutive calcium/calmodulin-dependent nitric oxide (NO) syn~hasc cxprcsscd in vascular endothclium shams common biochcmjcal and 
pharmacologic properties with ncuronal NO synthasc. However. rcccnl cloning und molecular charaacrizalion of NO synthase from bovine 
endothclial cells indicated the existence of a family of constitutivo NO synlhascs. Accordingly, we undertook molecular cloning and scqucncc 
analysis of human cndothelial NO synthasc. Complemcruary DNA clones prcdicl a protein of 1,203 amino acids sharing 94% identity with the 
bovine cndothelial protein, but only 60% identity with the rut brain NO synlhasc isolbrm. Northern blot analysis with an endothclial-dcrivcdcDNA 
identitied a 4.6-4.8 kb mRNA transcript in IWVEC und in situ hybridization localized transcripts to vascular endothelium but not neuronal tissue. 
Cyclic GMP; Endothelium-derived relaxing I’lctor: Endothclium: Vascular smooth muscle; Vasodilatation 
I. INTRODUCTION 
Synthesis of nitric oxide (NO) by NO synthase derives 
from one of the two chemically equivalent guanidino 
nitrogens of t.-arginine, producing L-citrulline as a co- 
product [1,2]. In cndothelial cells and neuronal tissue, 
NO synthase enzymatic activity is constitutively ex- 
pressed but activation of the calcium/calmodulin sig 
nalling pathway is required for maximal activity [3,4]. 
Synthesis and release of NO is rapid and not dependent 
upon new protein synthesis. Dynamic control at the 
cellular level is through activation of specific cell surface 
receptors by calcium-mobilizing agonists. Constitutivc 
NO synthase contrasts with a pathway for NO synthesis 
evident in macrophages [S], Kupffer cells, hepatocytes, 
vascular smooth muscle [6], and mesangial cells [?I. Cal- 
cium/calmodulin-independent NO synthase activity is 
induced in these cell types by cytokines or bacterial wall 
products over a period of many hours. Induction of NO 
synthase activity is dependent upon new RNA and pro- 
tein synthesis. Biological ontrol for this NO synthase 
pathway is at the level of transcriptional activation 
[8] and appears to be controlled by the cytokine-re- 
sponse profile of the particular cell type. Sequence com- 
dbbreviutiunx HUVEC, human umbilical vein endothclial cells; kb. 
kilobases; PCR, polymerase chain reaction; TNF-a, tumor necrosis 
factor-alpha. 
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parison of recently isolated molecular clones for rat 
brain [4] and murine macrophage NO synthase [8,9] 
indicated that these proteins are the products of sepa- 
rate genes. 
The calcium/calmodulin-dependent NO synthases of 
endothelial cells and neuronal tissue, though similarly 
regulated and expressing identical cofactor require- 
ments, localize to different subcellular compartments 
[I 0] and vary in apparent molecular weight [l I]. To 
determine whether these constitutively expressed NO 
synthases were encoded by distinct genes we have re- 
cently purified bovine cercbellar NO synthase, deter- 
mined the amino acid composition of tryptic peptides, 
and used a PCR-based cloning strategy to isolate cDNA 
probes for bovine neuronal and bovine endothelial NO 
synthase [12]. Genomic southern analysis using neu- 
ronal and endothelial cDNAs identified unique restric- 
tion enzyme fragments indicating that these cDNA 
clones reflected the products of distinct genes. Further- 
more, isolation and expression of a full-length cDNA 
for bovine endothelial NO synthase in eukaryotic trans- 
fectants resulted in the acquisition of calcium-stimu- 
lated NO synthase activity, as well as NADPH diapho- 
rase activity. Sequence analysis of this full-length clone 
predicted a protein of 1205 amino acids that differed at 
numerous residues from the sequence determined for 
the purified bovine neuronal NO synthase. Moreover, 
bovine endothelial NO synthase showed only 50 and 
60% homology with recently identified murine macro- 
phage and rat brain NO synthases, respectively. These 
data were taken to indicate that bovine endothelial NO 
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Fig. 1. Comparison or human and bovine constitutive ndothelial nitric oxide synthases. The sequences arc numbered with rcspcct o the first 
potential initiator methioninc residue. Deduced amino acid sequence isdenoted with the single letter code. Identical amino acids are framed. A 
consensus scqucnce Car N-terminal myristoylation is noted (MYRIS). A potential phosphorylation site for cyclic AMP-dependent protein kinase 
(PKA) and a putative binding site for calmodulin (CALCIUM-CALMODULIN) is indicated. Cofactor consensus sites inciudc; iiavin mononucle- 
otide binding (FMN), R&n adeninc dinuclcotidc pysophosphate (FAD& il:: x-iiavin electron transport (FLAVIN), FAD-isoalioxazinc (FAD-I), 
nicotine adcninc dinucleotidc phosphate ribose (NADPH-R) and NADPM adcninc (NADPM-A). 289 
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synthass represented a novel member of a family of 
constitutive calcium/dependent NO synthnscs [ 121. 
Endothelium-dependent vasorelaxation is suggested 
co be impaired in important diseases of the human vas- 
cular wall; atherosclerosis, diabetes, and hypertension, 
among others. The ability to dissect he pathophysiol- 
ogic basis of these defects at the molecular level has been 
hampered by the lack of molecular clones for the human 
constitutive ndothelial NO synthase. The isolation of 
cDNA clones encoding the human constitutive ndothe- 
lial NO synthase is reported herein. 
2. MATERIALS AND METHODS 
2.1 ‘ Mure&rls 
Cell culture media were from Gibco, Grand Island, NY; cell culture 
plates from Costar. Cambridge, MA; human recombinant tumor nu. 
crosis factor-alpha (rHuTNFa, spcc. act. 9.8 x 10” U/mg) was a gift 
of Knoll Pharmaceuticals, Whippany, NJ; DNA restriclion and mod- 
ifying enzymes from Pharmaciu LKB. Baie d’lJrfe, Quebec; Taq DNA 
polymerase from Pcrkin.Elmcr Cctus, Emeryvillc, CA; all other rea- 
gents were us described [I31. 
2-7, cDNA clo~rrs 
Recombinant bacteriophage clones were isolated by plaque hybrid. 
ization from a random-primed HUVEC Apt I1 cDNA library with 
cDNA probes labellcd with [0P]dCTP (New England Nuclear, 
Wilmington, DE, spcc. act. 3000 Ci/mmol) by the random-primer 
method. Initial cDNA clones were isolated using a 400 bp bovine 
endothelial cD:\IA encoding amino acids 51G to 654 (bovine mid. 
region probe) of bovine endothclial NO spnthasc [12], A total of 5 
crass-hybridizing phage clones were isolated from 5.9 x 10” plaques 
screened. To isolate flanking sequences a 360 bp HUVEC cDNA 
encoding amino acids 1105 to 1203 and 3’ non-coding sequence (3’ 
probe), and a 3GO bp HUVEC cDNA encoding amino acids I3 to 134 
(5’ probe) of buman endothelial NO synthase were utilized, In total, 
IO and 15 cross-hybridizing phagc clones were isolated from screens 
of 5.0 x IO’ plaques, respectively. Cross-hybridizing clones were pla- 
que-puriiied, isolated by preparative agarosc gel clecuophoresis, ub. 
cloned into the &:coRI multiple cloning site of pBluescript I SK(-) 
(Srralagene, San Diego, CA), and subjected to dideony chum-termi. 
nalion sequence analysis with Scquenase 2.0 (US Biochemical Corp., 
Cleveland. OH). Oligonucleotide primers were synthesized on a. Phar- 
mafia LKB Gene Assembler Plus. Deduced nucleotide sequences were 
confirmed on both strands of multiple overlapping phage clones. 
2.3. Rapid uwtph~coriott 0J.S cDN.4 end (RACE prorocotj 
Modifications of the RACE protocol were utilized to isolate 50 
nuclcotides of 5’ coding sequence [14]. Briefly, human umbilical vein 
cndothelinl cells (WUVEC) total cellr+tr RNA (5 ~6) was reverse 
transcribed with an anti-sense gene-specitic primer (S- GCG CiGG 
AAC TCC AGG CCC -3’) by murinc moloney leukemia virus reverse 
transcriptase (Gibco BRLlLifc Technologies). RNase H (BRL) was 
utilized to remove mRNA [ 151. First stand cDNA product was tailed 
with dATP by lerminal deouynucleotidc transferase (BRL). First 
round PCR amplification was performed in a total volume of SO ,ul 
for 35 cycles at 45OC (Perkin-Elmer Cetus 480 thermocycler) (sense 
primers S’- GAC TCG AGT CGA CGA ATT CAA T,,,, -3’, 2 pmol; 
5’- GAC TCG AGT CGA CGA ATT CAA -3’, 25 pmol; anti-sense 
gene+pecitic primer S- AAT TTC CAG CAG CAT GTT -3, 25 
pmol). A second round of amplification was performed for 35 cycles 
at 55°C in a lotal volume of 5Oyl (sense primer 5’- GAC TCG AGT 
CGC CGA ATT CAA -3’, 35 pmol; antiscnse gene-specific primer 5’. 
TTC CCC CAC TGG ATC CGG CCC ACG CAG -3’, 35 pmol). 
Products ofthc desired size were isolated with prcparadve gel clectro- 
phonsis, digested with EcoRI/&tn~Hl, and subcloned into pBluescript 
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I SK(-). A library of 10J RACE-PCR products. translbrmed into 
DHlO/J clccirocompcieni cells (DRL), were screened with in situ calm 
ony lift hybridization using the above mentioned human 5’ cDNA 
probe. Multiple positive colonies were subjected to DNA sequence 
analysis to exclude PCRsL;ssociated nucleotidc incorporation errors. 
2.4. RNA isolurion, rtorrltcrrt blorlitlg cm/ lt_dtri&urion 
HUVEC were isolated and maintained as described II6]. Northern 
analysis was performed aspreviously published [ 131. A 790 bp human 
endothelial cDNA corresponding to amino acids 380 to 643 (human 
mid-region probe) was lubclled with the random~primcr method (5 x 
10bcpm/ml). flybridization and washes were p rformed under condi- 
tions of high stringency, Blots were rehybridizcd with a human @ 
tubulin cDNA under conditions of high stringency (0,75 kb EcoRl 
insert) (ATCC 77044) to control for the amount of RNA loaded per 
lane. A I.0 kb EroRIIP,srl restriction fragment, corresponding to 3’ 
coding and non-coding regions of human cytochrome P450 reductase. 
was also used in Northern analysis. This cDNA was isolated from an 
~eoRt/X/~oI dT-primed AZAP II human vascular smooth muscle 
cDNA library. 4.0 x IO5 plaques were screened with ihc human endo- 
thelial 3’ cDNA described above. VCS M13 helper phage allowed 
in-vitro phagemid rescue following manufacturer’s suggestions (Strat- 
ngene). 
Tissues wcrc collected atnecropsy from an adult human male and 
adult baboon and fixed in 4% pnraformaldchydc with 0.1 M NaPO, 
(pbl 7.4) for 3-4 h at 4°C cyloprotccted in 15% sucrose-PBS over- 
night, embedded in OCT, frozen in liquid nitrogen, and stored at 
-70°C. Cryosections (7-10~111) were thaw-mounted ontoVectabond_ 
(Vector Laboratories. Burlingumc. CA) coated-slides, refrozen, and 
stored at -70°C with desiccant until use. Theabovc.mcntioned human 
mid-region probe was transcribed with T3 RNA polymerasc 
(Promepa) using [I-“‘SIUTP (Amrrsham. Arlington Heights, IL, apcc. 
acl, 1200 CiImmol) 10 produce kI~~-knglh anti-sense transcripts. Ex- 
periments were controlled by hybridizing sections whb lhe same 
cDNA probe transcribed in the sense orientation with T7 RNA 
polymerase (Promega). Studies were performed as previously dc- 
scribed [17], Briefly, cryosections were pretreated with paraformaldc- 
hyde, proteinasc K (Sigma Chemical, St. Louis, MO), and prehybr- 
idized in 100 ~1 hybridization buffer (50% formamide, 0,3 M N&I, 
20 mM Tris-HCI pH 8.0, 5 mM EDTA, 0.02% polyvinylpyrrolidine, 
0.02% licoll, 0.02% bovine serum albumin, 10% dextran sulfale, and 
10 mM dithiothreitol) at 42OC. Serial sections were hybridized with 
6.0 x 10’ cpm ~‘5S]riboprobe/slidc at 55OC. After hybridization, the 
sections wcrc washed with 2 xSSC (I x SSC = 150 mM NaCI, 15 mM 
Nacitrate. pH 7.0) with 10 mMP-mercaptoethanol and I mM EDTA, 
lreutcd will1 RNasc A (Sigma), again washed in the same buffer, 
followed by a high slringency wash in 0.1 x SSC with IO mM pa 
mercaptoeihanol and 1 mM EDTA, at 55°C. Slides were then washed 
in 0.5 x SSC and dehydrated in graded alcohols containing 0.3 M 
NH,Ac. Sections were dried, coaled with NTB2 nuclear track ernul~ 
sion (Eastman Kodak, Rochcstcr. NY), and exposed in the dark at 
4°C for 4 to IO w’ecks. Alier development. the sections wcrc counter. 
stained with humatoxylin and eosin to aid in cell identilication, 
3. RESULTS AND DlSCUSSlON 
The nucleotide sequence(s) reported in this paper has 
been submitted to the GenBank/EMBL Data Bank with 
accession number(s) M95296. Nucleotide coding se- 
quences are 90% identical comparing human and bo- 
vine endothelial constitutive NO synthases. The 
methionine-encoding sequences near the 5’ end of the 
open reading frame have neighbouring nucleotide se- 
quences consistent with eukaryotic translational start 
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Fig. 2. Northern blot annlysis of constitutivc human cndothclial nitric 
oxide synthase; cfkct of TNF-a. In the upper panel total cellular RNA 
(IO pgllane) isolated from HUVEC; control (lunc I), TNF-a (100 
ndml, 4 h) (lane 2). TNF-1: (100 ngml. 24 h) (lane 3). Nylon mem- 
branes were probed with a ‘zP-labellcd constitutivc human endothelial 
NO synthase cDNA. In the lower panel membranes wcrc reprobed 
with a >‘P-lubclled human cytochromc P4SO reductasc cDNA. 
sites AGTAAC(ATG)G [18]. The deduced amino acid 
sequence of human endoehelial NO synthase, compris- 
ing 1203 amino acids, predicts a protein with a mw of 
133 kDa. This is in close agreement with lhe predicted 
molecular mass of bovine endothelial NO synthase 
(1205 amino acids) [121 as well as the molecular weight 
of 135 kDa suggested from purification of the enzyme 
from bovine endothelial cells [l I]. Indicated in Fig. I is 
an amino acid sequence comparison of the human and 
bovine endothelial NO synthases. The sequence is num- 
bered with respect to the first potential initiator 
methionine codon. 
Cellular fractionation has indicated that endothelial 
NO synthase may be localized to the particulate fraction 
ofendothelial cell preparations [IO]. This contrasts with 
the cytosolic localization of constitutive neuronal and 
inducible macrophage NO synthases. A consensus 
motif for N-terminal myristoylation is noted in both 
human and bovine endothelial sequences [19], Such a 
motif is not present in neuronal and macrophage N 
termini. Binding sites for cofactors and nucleotides are 
highly conserved between human and bovine endothe- 
lial NO synthases, indeed overall amino acid sequence 
identity is 94%. This contrasts with a predicted amino 
acid identity of 50 and GO% with murine macrophage 
and rat neuronal NO synthase, respectively. Constitu- 
tive human endothelial NO synthase reveals no signifi- 
cant sequence similarity over the initial 226 residues of 
neuronal NO synthase [4]. 
Northern blot analysis (Fig. 2, upper panel) indicated 
the most prominent mRNA transcript o be 4.6 to 4.8 
kb in size. We and others have previously demonstrated 
that proinflammatory cytokines, such as TNF-a, induce 
a pathway for NO synthesis in endothelial cells [20,21]. 
Addition of human recombinant TNF-a (100 @ml) for 
4 and 24 h failed to increase levels of endothelial NO 
synthase mRNA transcripts. l[n fact, such treatment dc- 
creased levels of constitutive cndothelial NO synthase 
mRNA when assessed at 24 h (n = 3). NO synthases 
show a high degree of homology to cytochrome P45O 
reductase [4]. This is especially evident at the CORM 
termini of the molecules, regions of putative nucleotide 
and cofactor interactions. A human cytochrome P450 
reductase cDNA was utilized to control for the amount 
of RNA loaded per lane (Fig. 2, lower panel). Similar 
results were obtained when blots were reprobed with a 
human P-tubulin cDNA (results not shown). Therefore, 
the increase in endothelial NO synthase activity induced 
by prolonged treatment with TN&LX is likely to involve 
post-transcriptional modification of NO synthase. in- 
duction of co-regulatory processes, or the induction of 
a distinct endothelial NO synthase isoform. 
Anti-sense cRNA probes were utilized under condi- 
tions of high stringency for in situ hybridization studies. 
These studies were performed to assess the cellular ex- 
pression of endothelial constitutive NO synthase. 
Shown in Fig. 3A is localization of NO synthase mRNA 
to vascular endothelium within a human intercostal ar- 
tery. In Fig. 3B constitutive ndothelial NO synthase 
mRNA was also localized in representative s ctions of 
baboon cerebellum solely to endothelial cells of blood 
vessels and not to neurons. In contrast o findings ob- 
tained with anti-sense riboprobes no hybridization sig- 
nal was detected using a sense riboprobe (data not 
shown). Endothelial cell identity was confirmed by UIcs 
europucus lectin immunohistochemistry [ 171 and in-situ 
hybridization using a von Willcbrand factor cRNA 
probe on adjacent serial sections [22]. Sucl9 studies dem- 
onstrated specific hybridization to endothelial NO syn- 
thase mRNA and not neuronal NO synthase mRNA. 
There are striking areas of regional amino acid ho- 
mology among the NO synthase family. Functional as- 
sessment of putative regulatory and functional domains 
are under active investigation. For instance, whether 
N-terminal myristoylation of endothelial NO synthase 
targets the protein to membranes remains to be deter- 
mined. Functional expression of a full-length cDNA for 
human endothelial NO synthase will be an important 
component of such studies. Bovine endolhelial NO syn- 
thase cDNAs clearly confer calcium-activated NO syn- 
thase activity in a hetcrologous system [ 121. We believe 
that the marked sequence identity as well as equivalent 
size and tissue distribution of mRNA transcripts, all 
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Fig. 3. Rcprescnlative sections of in situ localization ofconstitutive endothclial NO synlhase mRNA within n human intercostal artery (A) and 
baboon cerebellum (B). (A) NO synthasc mRNA was detected in the cndothcljal cells of a human intercostal artery by in situ hybridization using 
an endothclinl NO synthase [a-J5S]UTP-labelled cRNA probe. (B) NO synthasc expression was localized within baboon cerebellum solely to 
cndothelial cells of blood vessels and not neuronal tissue. Similar results wcrc obtained on serial sections hybridized to a human von Willcbrand 
factor [a-“S]UTP-labelled cRNA probe. Serial sections hybridized with ;I corresponding sense human c dothulial NO synthase [a-35SIUTP-labclled 
cRNA probe did not show hybridization. Autoradiographs were photngraphcd using a combination of bright field illumination and polarized 
epi-illumination. A. 1250x; B. 416% 
suggest hat these cDNA clones encode the human and 
bovine constitutive endothelial isoforms. Indeed, the 
current study suggests that isoforms may be highly con- 
served across pecies. The isolation of human sequences 
may now allow direct assessment of endothclial NO 
synthase mRNA expression in important vascular dis- 
eases of man and permit studies of genomic organiza- 
tion and transcriptional regulation. 
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